Immunophenotypes of anti-SARS-CoV-2 responses associated with fatal COVID-19.

ABSTRACT:

Background

The relationship between anti-SARS-CoV-2 humoral immune response, pathogenic inflammation, lymphocytes and fatal COVID-19 is poorly understood.

Methods

A longitudinal prospective cohort of hospitalised patients with COVID-19 (n=254) was followed up to 35 days after admission (median, 8 days). We measured early anti-SARS-CoV-2 S1 antibody IgG levels and dynamic (698 samples) of quantitative circulating T-, B- and natural killer lymphocyte subsets and serum interleukin-6 (IL-6) response. We used machine learning to identify patterns of the immune response and related these patterns to the primary outcome of 28-day mortality in analyses adjusted for clinical severity factors.

Results

Overall, 45 (18%) patients died within 28 days after hospitalisation. We identified six clusters representing discrete anti-SARS-CoV-2 immunophenotypes. Clusters differed considerably in COVID-19 survival. Two clusters, the anti-S1-IgG^lowestT^lowestB^lowestNK^modIL-6^mod, and the anti-S1-IgG^highT^lowB^modNK^modIL-6^highest had a high risk of fatal COVID-19 (HR 3.36-21.69; 95% CI 1.51-163.61 and HR 8.39-10.79; 95% CI 1.20-82.67; p≤0.03, respectively). The anti-S1-IgG^highestT^lowestB^modNK^modIL-6^mod and anti-S1-IgG^lowT^highestB^highestNK^highestIL-6^low cluster were associated with moderate risk of mortality. In contrast, two clusters the anti-S1-IgG^highT^highB^modNK^modIL-6^low and anti-S1-IgG^highestT^highestB^highNK^highIL-6^lowest clusters were characterised by a very low risk of mortality.

Conclusions

By employing unsupervised machine learning we identified multiple anti-SARS-CoV-2 immune response clusters and observed major differences in COVID-19 mortality between these clusters. Two discrete immune pathways may lead to fatal COVID-19. One is driven by impaired or delayed antiviral humoral immunity, independently of hyper-inflammation, and the other may arise through excessive IL-6-mediated host inflammation response, independently of the protective humoral response. Those observations could be explored further for application in clinical practice.

SUBMITTER: Selb J 

PROVIDER: S-EPMC9510901 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature